Psychedelic Medicine Market Size, Share, Growth, and Industry Analysis, By Type (oral, intranasal, intravenous, and others), By Application (gamma-hydroxybutyrate, ketamine, psilocybin, MDMA, and others), and Regional Insights and Forecast to 2033

Detailed TOC of Global Psychedelic Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2025-2033

Table of Content

1 Psychedelic Medicine Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Psychedelic Medicine Market Size (2018-2028)
1.3.1 Global Psychedelic Medicine Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Psychedelic Medicine Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Psychedelic Medicine Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Psychedelic Medicine Historic Revenue ($) by Type (2018-2023)
2.2 Global Psychedelic Medicine Historic Sales Volume by Type (2018-2023)
2.3 Oral Sales and Price (2018-2023)
2.4 Intranasal Sales and Price (2018-2023)
2.5 Intravenous Sales and Price (2018-2023)
2.6 Others Sales and Price (2018-2023)

3 Global Psychedelic Medicine Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Psychedelic Medicine Historic Revenue ($) by Application (2018-2023)
3.2 Global Psychedelic Medicine Historic Sales Volume by Application (2018-2023)
3.3 Gamma-hydroxybutyrate Sales, Revenue and Growth Rate (2018-2023)
3.4 Ketamine Sales, Revenue and Growth Rate (2018-2023)
3.5 Psilocybin Sales, Revenue and Growth Rate (2018-2023)
3.6 MDMA Sales, Revenue and Growth Rate (2018-2023)
3.7 Others Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Psychedelic Medicine Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Psychedelic Medicine Industry News
4.7.2 Psychedelic Medicine Industry Policies

5 Global Psychedelic Medicine Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Psychedelic Medicine Sales Volume by Region (2018-2023)
5.2 Global Psychedelic Medicine Market Revenue ($) by Region (2018-2023)

6 Global Psychedelic Medicine Import Volume and Export Volume by Major Regions
6.1 Global Psychedelic Medicine Import Volume by Region (2018-2023)
6.2 Global Psychedelic Medicine Export Volume by Region (2018-2023)

7 North America Psychedelic Medicine Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Psychedelic Medicine Sales Volume and Growth Rate (2018-2023)
7.2 North America Psychedelic Medicine Market Trends Analysis Under Global Inflation
7.3 North America Psychedelic Medicine Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific Psychedelic Medicine Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Psychedelic Medicine Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Psychedelic Medicine Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Psychedelic Medicine Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Psychedelic Medicine Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)

9 Europe Psychedelic Medicine Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Psychedelic Medicine Sales Volume and Growth Rate (2018-2023)
9.2 Europe Psychedelic Medicine Market Trends Analysis Under Global Inflation
9.3 Europe Psychedelic Medicine Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)

10 Latin America Psychedelic Medicine Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Psychedelic Medicine Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Psychedelic Medicine Market Trends Analysis Under Global Inflation
10.3 Latin America Psychedelic Medicine Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa Psychedelic Medicine Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Psychedelic Medicine Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Psychedelic Medicine Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Psychedelic Medicine Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Psychedelic Medicine Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Psychedelic Medicine Revenue ($) and Market Share of Key Players
12.1.2 Global Psychedelic Medicine Sales Volume and Market Share of Key Players
12.1.3 Global Psychedelic Medicine Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Mindset Pharma Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Mindset Pharma Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 Pfizer Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 Pfizer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 NUMINUS WELLNESS INC WS Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 NUMINUS WELLNESS INC WS Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 AbbVie Inc. Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 AbbVie Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 TRYP Therapeutics Inc Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 TRYP Therapeutics Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Jazz Pharmaceuticals Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Jazz Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 MindMed Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 MindMed Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Mydecine Innovations Group Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Mydecine Innovations Group Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 COMPASS Pathways PLC Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 COMPASS Pathways PLC Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 Cybin Inc. Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 Cybin Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 Johnson & Johnson Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 Johnson & Johnson Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Psychedelic Medicine Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Psychedelic Medicine
13.3.3 Raw Material Cost of Psychedelic Medicine
13.3.4 Labor Cost of Psychedelic Medicine
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Psychedelic Medicine Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Psychedelic Medicine Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Psychedelic Medicine Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Psychedelic Medicine Sales Volume Forecast by Type (2023-2028)
15.2 Global Psychedelic Medicine Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Psychedelic Medicine Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Psychedelic Medicine Sales Volume Forecast by Application (2023-2028)
15.3 Global Psychedelic Medicine Sales Volume Forecast by Region (2023-2028)
15.4 Global Psychedelic Medicine Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion